Press Release: European Medicines Agency concludes review of dose recommendations for anti-tuberculosis medicines used in children

Author (Corporate)
Series Title
Series Details EMA/CHMP/123373/2012 (17.2.12)
Publication Date 17/02/2012
Content Type

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), in February 2012, concluded its review of dosing recommendations from the World Health Organization (WHO) for first-line anti-tuberculosis medicines in children.
Source Link http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2012/02/news_detail_001445.jsp&mid=WC0b01ac058004d5c1&murl=menus/news_and_events/news_and_events.jsp
Related Links
EMA: Press Release: EMA/CHMP/123373/2012 (17.2.12): European Medicines Agency concludes review of dose recommendations for anti-tuberculosis medicines used in children http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2012/02/WC500122910.pdf
Subject Categories
Countries / Regions